Blog
About

150
views
0
recommends
+1 Recommend
0 collections
    20
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Nanocarriers as an emerging platform for cancer therapy.

      Nature nanotechnology

      drug therapy, Neoplasms, ultrastructure, chemistry, Nanostructures, trends, Nanomedicine, Drug Compounding, Drug Carriers, administration & dosage, Antineoplastic Agents

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nanotechnology has the potential to revolutionize cancer diagnosis and therapy. Advances in protein engineering and materials science have contributed to novel nanoscale targeting approaches that may bring new hope to cancer patients. Several therapeutic nanocarriers have been approved for clinical use. However, to date, there are only a few clinically approved nanocarriers that incorporate molecules to selectively bind and target cancer cells. This review examines some of the approved formulations and discusses the challenges in translating basic research to the clinic. We detail the arsenal of nanocarriers and molecules available for selective tumour targeting, and emphasize the challenges in cancer treatment.

          Related collections

          Author and article information

          Journal
          10.1038/nnano.2007.387
          18654426

          Comments

          Comment on this article